Cargando…
American Society of Clinical Oncology’s Global Oncology Leadership Task Force: Findings and Actions
In response to rising cancer incidence and mortality rates in low- and middle-income countries and the increasingly global profile of ASCO’s membership, the ASCO Board of Directors appointed the Global Oncology Leadership Task Force (Task Force) to provide recommendations on ASCO’s engagement in glo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180769/ https://www.ncbi.nlm.nih.gov/pubmed/30241187 http://dx.doi.org/10.1200/JGO.17.00060 |
_version_ | 1783362278067798016 |
---|---|
author | Hortobagyi, Gabriel N. Pyle, Doug Cazap, Eduardo L. El Saghir, Nagi S. Shulman, Lawrence N. Lyman, Gary H. Schnipper, Lowell E. Adebamowo, Clement Adebayo Gandara, David R. Vose, Julie Wong, Sandra L. Yu, Peter |
author_facet | Hortobagyi, Gabriel N. Pyle, Doug Cazap, Eduardo L. El Saghir, Nagi S. Shulman, Lawrence N. Lyman, Gary H. Schnipper, Lowell E. Adebamowo, Clement Adebayo Gandara, David R. Vose, Julie Wong, Sandra L. Yu, Peter |
author_sort | Hortobagyi, Gabriel N. |
collection | PubMed |
description | In response to rising cancer incidence and mortality rates in low- and middle-income countries and the increasingly global profile of ASCO’s membership, the ASCO Board of Directors appointed the Global Oncology Leadership Task Force (Task Force) to provide recommendations on ASCO’s engagement in global oncology. To accomplish its work, the Task Force convened meetings of global oncology experts, conducted focus group discussions with member groups, did site visits to South America and India, and met regularly to analyze the findings and develop recommendations. Task Force findings included global concerns, such as access to care, and specific concerns of middle- and low-resource settings. The need to strengthen health systems and the importance of alliances with a range of international cancer stakeholders were emphasized. Task Force recommendations to the ASCO Board of Directors were based on a three-part global oncology strategy of professional development, improvement of access to quality care, and acceleration of global oncology research. Specific areas of focus within each of these strategic pillars are provided along with an update on areas of ASCO activity as these recommendations are implemented. |
format | Online Article Text |
id | pubmed-6180769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-61807692018-11-13 American Society of Clinical Oncology’s Global Oncology Leadership Task Force: Findings and Actions Hortobagyi, Gabriel N. Pyle, Doug Cazap, Eduardo L. El Saghir, Nagi S. Shulman, Lawrence N. Lyman, Gary H. Schnipper, Lowell E. Adebamowo, Clement Adebayo Gandara, David R. Vose, Julie Wong, Sandra L. Yu, Peter J Glob Oncol Special Article In response to rising cancer incidence and mortality rates in low- and middle-income countries and the increasingly global profile of ASCO’s membership, the ASCO Board of Directors appointed the Global Oncology Leadership Task Force (Task Force) to provide recommendations on ASCO’s engagement in global oncology. To accomplish its work, the Task Force convened meetings of global oncology experts, conducted focus group discussions with member groups, did site visits to South America and India, and met regularly to analyze the findings and develop recommendations. Task Force findings included global concerns, such as access to care, and specific concerns of middle- and low-resource settings. The need to strengthen health systems and the importance of alliances with a range of international cancer stakeholders were emphasized. Task Force recommendations to the ASCO Board of Directors were based on a three-part global oncology strategy of professional development, improvement of access to quality care, and acceleration of global oncology research. Specific areas of focus within each of these strategic pillars are provided along with an update on areas of ASCO activity as these recommendations are implemented. American Society of Clinical Oncology 2017-08-11 /pmc/articles/PMC6180769/ /pubmed/30241187 http://dx.doi.org/10.1200/JGO.17.00060 Text en © 2017 by American Society of Clinical Oncology http://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Special Article Hortobagyi, Gabriel N. Pyle, Doug Cazap, Eduardo L. El Saghir, Nagi S. Shulman, Lawrence N. Lyman, Gary H. Schnipper, Lowell E. Adebamowo, Clement Adebayo Gandara, David R. Vose, Julie Wong, Sandra L. Yu, Peter American Society of Clinical Oncology’s Global Oncology Leadership Task Force: Findings and Actions |
title | American Society of Clinical Oncology’s Global Oncology
Leadership Task Force: Findings and Actions |
title_full | American Society of Clinical Oncology’s Global Oncology
Leadership Task Force: Findings and Actions |
title_fullStr | American Society of Clinical Oncology’s Global Oncology
Leadership Task Force: Findings and Actions |
title_full_unstemmed | American Society of Clinical Oncology’s Global Oncology
Leadership Task Force: Findings and Actions |
title_short | American Society of Clinical Oncology’s Global Oncology
Leadership Task Force: Findings and Actions |
title_sort | american society of clinical oncology’s global oncology
leadership task force: findings and actions |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180769/ https://www.ncbi.nlm.nih.gov/pubmed/30241187 http://dx.doi.org/10.1200/JGO.17.00060 |
work_keys_str_mv | AT hortobagyigabrieln americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT pyledoug americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT cazapeduardol americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT elsaghirnagis americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT shulmanlawrencen americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT lymangaryh americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT schnipperlowelle americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT adebamowoclementadebayo americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT gandaradavidr americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT vosejulie americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT wongsandral americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions AT yupeter americansocietyofclinicaloncologysglobaloncologyleadershiptaskforcefindingsandactions |